JUN 28, 2017 10:30 AM PDT

WEBINAR: Variant detection in cell-free DNA from NSCLC using NGS

Speakers
  • Associate Professor, Princess Margaret Cancer Centre
    Biography
      Dr. Stockley is a clinical molecular geneticist and Associate Director of the Molecular Diagnostics Division at the University Health Network, providing leadership within the two divisional molecular diagnostic laboratories. She is a member of the Board of Directors of the Canadian College of Medical Geneticists, the Canadian representative to the International Organization for Standardization Working Group on Molecular Diagnostics, and a member of the Laboratory Accrediation Advisory Panel for the Institute for Quality Management in Healthcare. Dr. Stockley's interests include the development of novel molecular diagnostic testing using high-throughput methodologies, and implementation and evaluation of genetic and genomic tests, particularly for acquired and inherited cancers.

    Abstract:

    DATE: June 28, 2017
    TIME: 10:30am PT, 1:30pm ET

    This webinar will describe the implementation of the Oncomine Lung cfDNA Assay from Thermo Fisher Scientific in the Advanced Molecular Diagnostic Laboratory at the Princess Margaret Cancer Centre in Toronto, Canada.  Dr. Stockley will describe the Princess Margaret experience using the Oncomine Lung cfDNA assay for detection of variants in circulating cell-free DNA from non-small cell lung cancer (NSCLC) samples.  The usefulness of detection of the EGFR T790M resistance mutation in cell-free DNA, and comparison to EGFR T790M detection by droplet digital PCR (ddPCR), will also be presented. 

    Learning objectives:

    • Understand the utility of the Oncomine Lung cfDNA for testing of cell-free DNA for NSCLC
    • Describe the advantages of using the Oncomine Lung cfDNA for detection of the EGFR T790M resistance mutation as compared to droplet digital PCR (ddPCR

    For RUO.  Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    JUN 29, 2018 09:00 AM PDT
    C.E. CREDITS
    JUN 29, 2018 09:00 AM PDT
    DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
    Loading Comments...